Ratutrelvir (83-0060)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19NCT07157007TRAWPhase 2Completed2026-02-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.